文献速递糖尿病

1型与胰岛素治疗2型糖尿病低血糖的性别差异:Hypo-METRICS研究

Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.
PubMed 文献 · Diabetologia · 2026-06-20

Hypo-METRICS为10周前瞻性横断面观察研究,纳入274例1型糖尿病和321例胰岛素治疗2型糖尿病患者,使用盲态CGM和专用App实时记录低血糖症状。两队列中性别间低血糖时间无显著差异(均p>0.05),但女性每周报告的症状性低血糖发作次数更多:1型糖尿病队列4.3 vs 3.3次/周(p=0.003),2型糖尿病队列1.4 vs 1.0次/周(p=0.006)。女性报告的症状组合范围更广。

要点

  • 尽管低血糖暴露相似,女性报告的症状性低血糖发作频率高于男性。
  • 1型糖尿病女性报告的症状组合范围更广,涵盖自主神经和神经低血糖症状。
  • 2型糖尿病男性中单独意识模糊占0.3%的症状性发作,女性中未观察到。

核心结论

  • 在自由生活环境中,尽管低血糖暴露相似,但性别间低血糖症状存在差异。
  • 需要进一步研究阐明这些发现的潜在原因。

研究设计与样本

  • Hypo-METRICS研究为10周前瞻性、横断面观察性研究,探讨低血糖体验。
  • 纳入274例1型糖尿病患者和321例胰岛素治疗2型糖尿病患者。
  • 参与者佩戴盲态持续葡萄糖监测(CGM)设备,并使用专用Hypo-METRICS App实时记录低血糖症状。

主要发现

  • 1型糖尿病队列中女性占54%,整个队列76%常规使用CGM;2型糖尿病队列中男性占63%,整个队列41%常规使用CGM。
  • 两队列中性别间低血糖时间均无显著差异(所有p>0.05)。
  • 1型糖尿病队列女性每周报告症状性低血糖发作次数多于男性(4.3 vs 3.3次/周,p=0.003)。
  • 2型糖尿病队列女性每周报告症状性低血糖发作次数多于男性(1.4 vs 1.0次/周,p=0.006)。
  • 1型糖尿病队列女性报告的症状组合范围更广,涵盖自主神经和神经低血糖症状;单独意识模糊占女性发作的0.9%、男性发作的2.3%。

关键数值与推荐

  • 症状性低血糖定义为血糖<4 mmol/l或任何经碳水化合物摄入缓解的低血糖症状发作。
  • 低血糖症状定义为自主神经症状(饥饿、出汗、颤抖、心悸)或神经低血糖症状(意识模糊、言语困难、协调困难、头痛)。

临床怎么用

  • 临床评估低血糖时需关注性别差异,女性可能报告更多症状性发作。
  • 对使用胰岛素治疗的患者,应个体化询问低血糖症状组合,尤其是神经低血糖症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to explore associations between gender and hypoglycaemia experience among people with type 1 diabetes or insulin-treated type 2 diabetes in a free-living environment in the Hypo-METRICS study. METHODS: The Hypo-METRICS study was a 10-week prospective, cross-sectional observational study of the hypoglycaemia experience. Participants (274 with type 1 diabetes and 321 with type 2 diabetes) wore blinded continuous glucose monitor (CGM) devices and recorded their hypoglycaemia symptoms in real time using a bespoke Hypo-METRICS app. Symptomatic hypoglycaemia was defined as a glucose level <4 mmol/l or any episode of hypoglycaemic symptoms that was resolved by carbohydrate ingestion. Hypoglycaemia symptoms were defined as autonomic (hunger, sweating, shaking, palpitations) or neuroglycopenic (confusion, difficulty speaking, coordination difficulties, headache). Differences between genders were assessed using χ2, Fisher's exact and Wilcoxon rank-sum tests and combination analyses. RESULTS: In the type 1 diabetes cohort, 54% were women and 76% of the entire cohort used CGM routinely. In the type 2 diabetes cohort, 63% were men and 41% of the entire cohort used CGM routinely. There were no significant differences in time in hypoglycaemia between genders in either cohort (all p>0.05), but women reported more episodes of symptomatic hypoglycaemia per week (4.3 vs 3.3 episodes/week in the type 1 diabetes cohort [p=0.003]; 1.4 vs 1.0 episodes/week in the type 2 diabetes cohort [p=0.006]). In the type 1 diabetes cohort, women reported a broader range of symptom combinations, spanning autonomic and neuroglycopenic symptoms. Confusion was the only reported symptom of hypoglycaemia in 0.9% of episodes in women and 2.3% of episodes in men. In the type 2 diabetes cohort, there were more symptom combinations, and both genders reported a combination of autonomic and neuroglycopenic symptoms. Confusion alone accounted for 0.3% of symptomatic episodes in men in the type 2 diabetes cohort; confusion alone was not observed in women. CONCLUSIONS/INTERPRETATION: Despite similar exposures to hypoglycaemia, there were differences in hypoglycaemia symptoms between genders in this free-living environment. Further work is needed to elucidate the potential underlying causes of these findings.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. McCarthy A, Kent G, Thomas J, et al. Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study. Diabetologia. 2026. PMID: 42322375. doi:10.1007/s00125-026-06775-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。